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CSF outflow through the cribriform plate near the olfac-
tory nerves and the outflow along brain and spinal nerves 
are together known as peripheral CSF outflow pathway 
(PCOP). It is still not clear whether the PCOP has pathoge-
netic relevance. Our previous clinical observations have in-
dicated that CSF may interact with nerves along the PCOP 
and in this article we present our finding of CSF outflow 
demonstrated by myelography in a single patient. We also 
discuss unexplained experimental pain pathomechanisms 
against the background of the PCOP hypothesis. We ob-
served that CSF flowed along lumbar nerves in distal direc-
tion at a speed of about 10 cm per hour on its way through 
the tissues, mainly muscles. Total CSF outflow volume at 
the lumbar site was remarkable. CSF outflow at lumbar 
nerves was also documented by neuroradiology. It is plau-
sible that CSF signaling serves for interaction with nerves 
along the PCOP, which could explain previously unknown 
pathomechanisms in pain generation. Experimental find-
ings of tactile pain hypersensitivity within lumbosacral 
pain pathways could be explained by releasing of mol-
ecules, microparticles, or exosomes into the CSF by mast 
cells, which then move with CSF outflow along the PCOP 
and interact with nerves, initiating even retrograde synap-
tic stripping.
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INTRODUCTION: THE PERIPHERAL CSF OUTFLOW 
PATHWAYS (PCOP)
It has been traditionally accepted that cerebrospinal fluid 
(CSF) flows from the subarachnoid spaces (SAS) through 
the cribriform plate into the cervical lymphatics, and simi-
larly, along all brain nerves and all peripheral nerves into the 
respective tissues. This CSF outflow can transport antigens 
from CSF spaces to the extracellular fluid of peripheral tis-
sues, which are then collected into the lymphatic system 
(1). CSF outflow through the cribriform plate to cervical 
lymphatics has been shown to be important for CNS-spe-
cific immune responses (2,3), but CSF outflow along (other) 
brain nerves and spinal nerves has been only poorly inves-
tigated. Our previous research investigated low level neu-
roinflammation (LLNI) subgroups in severe psychiatric dis-
orders (4). Affective and schizophrenia spectrum disorders 
may be accompanied by pain and other sensory symptoms 
(5), which could be explained at least in part by LLNI path-
omechanisms that arise from an interaction between CSF 
and peripheral nerves along the PCOP. It is also suggested 
that PCOP-associated symptoms prevail in classic neuroin-
flammation and possibly even in systemic inflammation (6). 
CSF has been found to have an important signaling func-
tion; CNS volume transmission involves signaling within the 
CNS extracellular spaces with a link to CSF signaling (7).
THE PCOP HYPOTHESIS
We performed CSF filtration as experimental therapy in 
cases of severe therapy resistant depression or schizophre-
nia, with the hypothesis that LLNI states may be respon-
sible for therapy resistance (8). During such experimental 
CSF filtration procedures performed daily over five days 
via lumbar intrathecal catheter, we observed a surprising-
ly rapid improvement of even chronic pain (9-11). In such 
cases, the CSF analysis showed LLNI to be present in the 
SAS. Thus, we assumed that chronic pain resulted from an 
interaction between pathogenic CSF contents and the spi-
nal cord and/or spinal nerves roots within the SAS. There 
however remained specific clinical details to be explained: 
for example, in some cases pain perception showed wax-
ing-waning asymmetries and was accompanied by slight 
paresis, both symptoms being prevalent over months. 
These specific aspects cannot be explained by interactions 
of pathogenetic CSF and nervous system exclusively with-
in the SAS, as this would likely elicit symmetric appear-
ance of symptoms. Thus, the idea was that CSF signaling 
came from more distal sites, meaning PCOP (9). Based 
on such observations and on extensive literature, a 
detailed PCOP hypothesis was formulated (6), proposing a 
complex scenario of interactions between CSF and poten-
tially all parts of the CNS that are in contact with the CSF. 
This would include the hypothetic CSF signaling on brain 
nerves and peripheral nerves along the PCOP through the 
tissues, including free nerves ends, where CSF outflow 
winds up. In conditions with abnormal CSF content, like in 
LLNI states or in classical neuroinflammation, such interac-
tions at the PCOP sites might cause local dysfunctions and 
symptoms. However these symptoms might not be easily 
detected, as the PCOP is distributed throughout the whole 
body, and might be interpreted to be coming from blood, 
as blood is a ubiquitous signaling system. Thus, PCOP as-
sociated symptoms could be differentiated from blood-
associated symptoms only by minor local typological dif-
ferences. Such CSF signaling-related symptoms may be 
waxing-waning symptoms, slight asymmetries, or differ-
ent distribution of symptoms in larger body parts related 
to changes of posture with presumed associated CSF out-
flow variations (6).
PCOP HYPOTHESIS AS A POSSIBLE EXPLANATION FOR 
WIDESPREAD TACTILE PAIN HYPERSENSITIVITY
Levy et al (12) investigated widespread tactile pain hy-
persensitivity from activated trigemino-cervical and lum-
bosacral pain pathways induced by mast cell degranula-
tion, but it remained unsolved what mechanism mediated 
hind paw hypersensitivity; for example with the available 
hypothesis it was difficult to explain the details of the time 
course of the changes. We would like to contribute to 
these observations by proposing a following scenario in-
volving the PCOP.
1. In general, CSF signaling can be mediated by solutes, es-
pecially proteins, cells, exosomes, microvesicles, or micropar-
ticles containing powerful signaling molecules (7,13).
2. CSF flows from the SAS along the PCOP between the 
epineurium and perineurium, making its way down (or dis-
tally from the SAS) the nerves all along its course touching 
also the neuronal ganglia. It eventually reaches the periph-
eral tissues at the area where nerves end and CSF outflow 
winds up to join the extracellular tissue fluid.
3. Any pathogenic CSF contents might potentially inter-
act with nerves at all PCOP sites where such interaction 
is possible, causing pathogenetic consequences at differ-
ent sites from the SAS to the nerve ends, and even to the 
neighboring tissues near nerve ends.
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4. Pathogenic CSF contents may for example be released 
to the SAS from mast cells within the meninges near the 
SAS. Molecules and particles released by mast cell degran-
ulation could then reach through CSF outflow all PCOP 
sites and elicit local effects:
a) At peripheral neuronal ganglia the pathogenic CSF con-
tents may easily elicit retrograde synaptic stripping at the 
spinal cord level and thus contribute to pain hypersensi-
tivity generation (personal communication with Georg 
Kreutzberg) (14, see references 29,30 in 14).
b) In the experiments by Levy et al (12), the mast cell de-
granulation took place in many tissues and at many sites 
including the meninges (dura), but was especially strong 
near free nerve ends. Molecules released into both, the SAS 
or near free nerves ends, could act together. Also locally 
released signaling molecules (from mast cells or others) 
might gain new effector qualities at local sites when they 
interact with CSF, or CSF signaling could influence locally 
residing cells, which could then become activated to en-
hance other pathogenic downstream mechanisms.
c) Unfortunately the CSF outflow patterns and local vol-
umes at various parts of the PCOP appear to be rather 
speculative. CSF outflow may depend on the posture (6) 
and experiments with absorption of radioactive tracers 
showed that it also depended on motor activity, when it 
was nearly doubled (15). These authors interpreted the dis-
appearance of tracer from the SAS as absorption, but they 
could not differentiate absorption from outflow, because 
of the technical approach they used. Edsbagge et al (15) 
instead clearly demonstrated CSF outflow (see for compar-
ison the evident considerable CSF outflow volume along 
lumbar nerves during routine myelography in our case).
d) CSF outflow and signaling by solutes along the PCOP 
may be accompanied by trafficking (and signaling) of CSF 
cells along the PCOP. CSF cell trafficking along the PCOP 
was proven at the cribriform plate, after which it reached 
the cervical lymphatics (2,16,17). It is plausible that CSF cell 
trafficking may similarly take place in all other parts of the 
PCOP, that is, brain nerves and spinal nerves, but there is still 
a lack of evidence to confirm this. We have recently dem-
onstrated in a single case that leukemia cells followed the 
PCOP from the subarachnoid spaces along lumbar nerves 
found most distally in subcutaneous tissues (18). Thus, CSF 
cells in general may have the potential of trafficking along 
the PCOP and possibly contributing to local pathogenic or 
protective mechanisms at the PCOP.
PHYSIOLOGICAL CSF OUTFLOW AT LUMBAR NERVES IN 
HUMANS DEMONSTRATED BY NEURORADIOLOGICAL 
APPROACH
In a patient undergoing lumbar myelography we observed 
physiological CSF outflow at lower body nerves, near the in-
jection site (Figure 1). The patient was examined for clinical 
reasons unrelated to this study. There was immediate distri-
bution of the contrast medium throughout the neighboring 
SASs, at all the neighboring nerve roots (Figure 2), and down 
the respective peripheral nerves (Figure 3-5). The cause of 
this CSF outflow cannot be increased intrathecal pressure 
from injection since we observed a similar finding in many 
cases before. Also, this can be excluded on the basis of logi-
cal considerations since after injection of the contrast agent 
into the SAS the intrathecal pressure may at best increase for 
a few seconds, because injection was performed slowly and 
an equivalent volume of CSF was removed before injection. 
Apparently, the contrast agent (now dissolved in the CSF) 
follows the natural course of CSF outflow along the nerves. 
The pattern of distribution is not compatible with a diffuse 
distribution or absorption from the SAS into the neighbor-
ing tissues, but with the CSF outflow scenario as proposed 
by the PCOP hypothesis (6). Although our neuroradiologi-
FIGURE 1. Lateral view of the spine with the needle inserted 
into the lumbar subarachnoid spaces. The water soluble 
contrast agent (15 mL Solutrast 250M) was just injected and 
distributed immediately throughout the lumbar subarachnoid 
space (in black). Time 15:48.
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cal pictures do not allow us to exactly define the anatomi-
cal borders of the outflow pathway and determine wheth-
er these borders definitely represent the epineurium and 
perineurium, they support such assumption. We observed 
that CSF roughly began to distribute from the SASs into 
the neighboring psoas muscle following the course of the 
nerve through the tissues. The outflow velocity was about 
50 mm per 30 minutes (Figure 4). In addition, CSF slightly 
and diffusely distributed into the tissues closely adjacent to 
the nerve at many sites along its outflow course (Figure 4,5). 
Such disappearance of contrast agent might be explained 
by diffusion through the natural borders, ie, nerve sheets, or 
alternatively may be produced by multiple small wind ups 
of the PCOP all along the nerve, ie, at multiple nerve muscle 
end plates. One should note that the anatomy of the wind 
up of the PCOP pathway has not yet been described in his-
tological detail.
OUTLOOK
There are still no studies dealing with CSF signaling at the 
PCOP sites, possibly mediated by various pathogenic CSF 
contents including solutes, microparticles, microvesicles, 
and cells. Our case is a rather typical finding, representing 
on overall CSF outflow velocity in still position of about 10 
cm per hour. More conclusive and systematic studies are 
needed to more precisely determine the CSF outflow vol-
umes and flow velocity along the PCOP, and interpersonal, 
intrapersonal, and local variability of CSF outflow. It is also 
important to define possible modulating factors of CSF 
outflow like age, sex, body mass, or the influence of mo-
tor activity. These aspects require systematic studies in ani-
mals and in humans.
Given the poorly explained mechanisms of pain genera-
tion in multiple sclerosis or experimental allergic encepha-
FIGURE 2. Posterior-anterior view of the spine (L = left) filling 
the lumbar subarachnoid space (black). The contrast agent 
has filled both sides (arrows) and the nerve root sleeves, which 
demonstrate part of the subarachnoid spaces. Time 15:51.
FIGURE 3. After injection of the contrast agent, CT scan 
was performed in prone position on a Philips Brilliance 40 
CT-Scanner (Hamburg, Germany) in spiral mode, collimation 
40 × 0.625 mm, 120 kV, 110 mAs. Multiplanar reconstructions 
were calculated. Time 16:13. Maximum intensity projection 
in anterior-posterior view showing the lumbar spine (lumbar 
vertebral bodies 1-5, see numbers). The contrast agent is now 
visible on both sides outside the subarachnoid space distribut-
ing parallel to the spinal nerves.
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litis (19), or in experiments on pain hypersensibility by Levy 
et al (12), the PCOP-associated pain pathomechanisms 
mediated through pathogenic CSF contents should be fur-
ther investigated. The widespread mast cell degranulation 
especially at the meninges observed in the experiments by 
Levy et al could be similar to LLNI or classical neuroinflam-
matory mechanisms (4).
Another question of interest was the overall balance be-
tween CSF production and CSF absorption outflow, the lat-
ter involving the outflow along the PCOP, glymphatic path-
way (20), absorption at arachnoid granulations, and the 
balance of fluid exchange between the brain and SAS (21).
Also, it would be interesting to examine the complex CSF 
flow patterns involving the pulsatile brain (22,23) as the pul-
satile brain drives volume transmission, which is balancing 
wiring transmission and is important for CSF signaling (7). 
The so called “roamer type” CSF signaling, which involves 
exosomes and microparticles (13), may help to better un-
derstand the unsolved questions and pathomechanisms 
in psychiatric and neurological disorders.
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